FROSCH Stefanie,FROSCH Stefanie,LINZ Klaus,LINZ Klaus,SCHIENE Klaus,SCHIENE Klaus
申请号：
SI201330918
公开号：
SI2849745T1
申请日:
2013.05.16
申请国别(地区):
SI
年份:
2018
代理人:
摘要：
The invention relates to a pharmaceutical composition comprising a first pharmacologically active ingredient, which is selected from (1r,4r)-6&prime-fluoro-N,N-dimethyl-4-phenyl-4&prime,9&prime-dihydro-3&primeH-spiro[cyclohexane-1,1&prime-pyrano[3,4,b]indol]-4-amine and the physiologically acceptable salts thereof, and a second pharmacologically active ingredient, which is a propionic acid derivative selected from the group consisting of ibuprofen, naproxen, ketoprofen, flurbiprofen, fenoprofen, fenbufen, suprofen, pirprofen, indoprofen, tiaprofenic acid, oxaprozin, ibuproxam, flunoxaprofen, alminoprofen, naproxcinod, and the physiologically acceptable salts thereof.
